Faricimab

In this video, Diana Do, MD, discusses the impact of socioeconomic disparities on patients with diabetic eye diseases.

In this video, Diana Do, MD, discusses treatment options available to patients with diabetic eye diseases.

In this expert perspective from Hawaiian Eye 2024, Jordan M. Graff, MD, FACS, discusses faricimab for the treatment of retinal vein occlusion.

WAILEA, Hawaii — In this Healio Video Perspective from Retina 2024, Jordan M. Graff, MD, FACS, describes a post hoc analysis of the YOSEMITE and RHINE clinical trials evaluating biomarkers for vascular stability.

In this Healio Video Perspective from Angiogenesis, Exudation, and Degeneration 2024, Arshad M. Khanani, MD, MA, FASRS, presents 1-year real-world findings for faricimab as a treatment for neovascular age-related macular degeneration.

In this expert perspective from Hawaiian Eye 2024, Roger A. Goldberg, MD, MBA, discusses the significance of the approval of Vabysmo from Genentech for the treatment of retinal vein occlusion.

In this expert perspective from Hawaiian Eye 2024, Roger A. Goldberg, MD, MBA, discusses what to expect for the treatment of retinal vein occlusion, or RVO, in 2024.

Patients with retinal vein occlusion who received Vabysmo experienced visual improvements as well as extended treatment intervals at 72 weeks, according to a study.

In this expert perspective from Hawaiian Eye 2024, Sunir J. Garg, MD, FACS, FASRS, discusses the 2023 FDA approval of faricimab for the treatment of retinal vein occlusion.

WAILEA, Hawaii — In this Healio Video Perspective from Retina 2024, Michael A. Singer, MD, presents data on dosing intervals for faricimab as a treatment for wet age-related macular degeneration and diabetic macular edema.